EAM Global Investors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-20,106
Closed -$1.83M 278
2021
Q3
$1.83M Sell
20,106
-15,017
-43% -$1.28M 0.43% 109
2021
Q2
$2.21M Buy
+35,123
New +$1.3M 0.61% 90

Other funds holding ASTH

EAM Global Investors's ASTH Position: Q4 2021 in Review

EAM Global Investors sold out of Astrana Health (ASTH) in Q4 2021, closing a stake of 20,106 shares — an estimated $1.83M sold.

EAM Global Investors first reported a position in ASTH in Q2 2021 and held it in 2 quarters. The position peaked at $2.21M in Q2 2021. 149 funds tracked by Wall St. Rank hold ASTH as of Q4 2021.

  • EAM Global Investors reported no remaining Astrana Health position as of Q4 2021 after selling out during the quarter.
  • EAM Global Investors sold 20,106 Astrana Health shares in Q4 2021, an estimated $1.83M.
  • EAM Global Investors first reported a position in Astrana Health in Q2 2021 and held it in 2 quarters.
  • EAM Global Investors's Astrana Health position peaked at $2.21M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Astrana Health as of Q4 2021.

Based on EAM Global Investors's 13F filing for Q4 2021, filed 11 Feb 2022.